176 related articles for article (PubMed ID: 12673672)
1. Frequent downregulation of DMBT1 and galectin-3 in epithelial skin cancer.
Mollenhauer J; Deichmann M; Helmke B; Müller H; Kollender G; Holmskov U; Ligtenberg T; Krebs I; Wiemann S; Bantel-Schaal U; Madsen J; Bikker F; Klauck SM; Otto HF; Moldenhauer G; Poustka A
Int J Cancer; 2003 Jun; 105(2):149-57. PubMed ID: 12673672
[TBL] [Abstract][Full Text] [Related]
2. Analysis of losses of heterozygosity of the candidate tumour suppressor gene DMBT1 in melanoma resection specimens.
Deichmann M; Mollenhauer J; Helmke B; Thome M; Hartschuh W; Poustka A; Näher H
Oncology; 2002; 63(2):166-72. PubMed ID: 12239452
[TBL] [Abstract][Full Text] [Related]
3. Carcinogen inducibility in vivo and down-regulation of DMBT1 during breast carcinogenesis.
Mollenhauer J; Helmke B; Medina D; Bergmann G; Gassler N; Müller H; Lyer S; Diedrichs L; Renner M; Wittig R; Blaich S; Hamann U; Madsen J; Holmskov U; Bikker F; Ligtenberg A; Carlén A; Olsson J; Otto HF; O'Malley B; Poustka A
Genes Chromosomes Cancer; 2004 Mar; 39(3):185-94. PubMed ID: 14732920
[TBL] [Abstract][Full Text] [Related]
4. UV-Induced Molecular Signaling Differences in Melanoma and Non-melanoma Skin Cancer.
Liu-Smith F; Jia J; Zheng Y
Adv Exp Med Biol; 2017; 996():27-40. PubMed ID: 29124688
[TBL] [Abstract][Full Text] [Related]
5. Expression of DMBT1, a candidate tumor suppressor gene, is frequently lost in lung cancer.
Wu W; Kemp BL; Proctor ML; Gazdar AF; Minna JD; Hong WK; Mao L
Cancer Res; 1999 Apr; 59(8):1846-51. PubMed ID: 10213490
[TBL] [Abstract][Full Text] [Related]
6. DMBT1 encodes a protein involved in the immune defense and in epithelial differentiation and is highly unstable in cancer.
Mollenhauer J; Herbertz S; Holmskov U; Tolnay M; Krebs I; Merlo A; Schrøder HD; Maier D; Breitling F; Wiemann S; Gröne HJ; Poustka A
Cancer Res; 2000 Mar; 60(6):1704-10. PubMed ID: 10749143
[TBL] [Abstract][Full Text] [Related]
7. Down-regulation of DMBT1 gene expression in human oral squamous cell carcinoma.
Imai MA; Moriya T; Imai FL; Shiiba M; Bukawa H; Yokoe H; Uzawa K; Tanzawa H
Int J Mol Med; 2005 Apr; 15(4):585-9. PubMed ID: 15754018
[TBL] [Abstract][Full Text] [Related]
8. An integrative model on the role of DMBT1 in epithelial cancer.
Mollenhauer J; Helmke B; Müller H; Kollender G; Krebs I; Wiemann S; Holmskov U; Madsen J; Otto HF; Poustka A
Cancer Detect Prev; 2002; 26(4):266-74. PubMed ID: 12430631
[TBL] [Abstract][Full Text] [Related]
9. Expression of the DMBT1 gene is frequently suppressed in human lung cancer.
Takeshita H; Sato M; Shiwaku HO; Semba S; Sakurada A; Hoshi M; Hayashi Y; Tagawa Y; Ayabe H; Horii A
Jpn J Cancer Res; 1999 Sep; 90(9):903-8. PubMed ID: 10551316
[TBL] [Abstract][Full Text] [Related]
10. Deleted in Malignant Brain Tumors 1 is a versatile mucin-like molecule likely to play a differential role in digestive tract cancer.
Mollenhauer J; Herbertz S; Helmke B; Kollender G; Krebs I; Madsen J; Holmskov U; Sorger K; Schmitt L; Wiemann S; Otto HF; Gröne HJ; Poustka A
Cancer Res; 2001 Dec; 61(24):8880-6. PubMed ID: 11751412
[TBL] [Abstract][Full Text] [Related]
11. Loss of heterozygosity in the MXI1 gene is a frequent occurrence in melanoma.
Ariyanayagam-Baksh SM; Baksh FK; Swalsky PA; Finkelstein SD
Mod Pathol; 2003 Oct; 16(10):992-5. PubMed ID: 14559981
[TBL] [Abstract][Full Text] [Related]
12. Decreased expression of galectin-3 in basal cell carcinoma of the skin.
Castronovo V; Liu FT; van den Brule FA
Int J Oncol; 1999 Jul; 15(1):67-70. PubMed ID: 10375595
[TBL] [Abstract][Full Text] [Related]
13. Expression patterns of S100 proteins in melanocytes and melanocytic lesions.
Petersson S; Shubbar E; Enerbäck L; Enerbäck C
Melanoma Res; 2009 Aug; 19(4):215-25. PubMed ID: 19521263
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical galectin-3 expression in non-melanoma skin cancers.
Kapucuoglu N; Basak PY; Bircan S; Sert S; Akkaya VB
Pathol Res Pract; 2009; 205(2):97-103. PubMed ID: 18951731
[TBL] [Abstract][Full Text] [Related]
15. Lack of DMBT1 expression in oesophageal, gastric and colon cancers.
Mori M; Shiraishi T; Tanaka S; Yamagata M; Mafune K; Tanaka Y; Ueo H; Barnard GF; Sugimachi K
Br J Cancer; 1999 Jan; 79(2):211-3. PubMed ID: 9888459
[TBL] [Abstract][Full Text] [Related]
16. The genomic structure of the DMBT1 gene: evidence for a region with susceptibility to genomic instability.
Mollenhauer J; Holmskov U; Wiemann S; Krebs I; Herbertz S; Madsen J; Kioschis P; Coy JF; Poustka A
Oncogene; 1999 Nov; 18(46):6233-40. PubMed ID: 10597221
[TBL] [Abstract][Full Text] [Related]
17. Sequential changes of the DMBT1 expression and location in normal lung tissue and lung carcinomas.
Mollenhauer J; Helmke B; Müller H; Kollender G; Lyer S; Diedrichs L; Holmskov U; Ligtenberg T; Herbertz S; Krebs I; Wiemann S; Madsen J; Bikker F; Schmitt L; Otto HF; Poustka A
Genes Chromosomes Cancer; 2002 Oct; 35(2):164-9. PubMed ID: 12203780
[TBL] [Abstract][Full Text] [Related]
18. Association of galectin-3 expression with melanoma progression and prognosis.
Brown ER; Doig T; Anderson N; Brenn T; Doherty V; Xu Y; Bartlett JM; Smyth JF; Melton DW
Eur J Cancer; 2012 Apr; 48(6):865-74. PubMed ID: 22071132
[TBL] [Abstract][Full Text] [Related]
19. Retinoblastoma gene expression in human non-melanoma skin cancer.
Edwards MJ; Thomas RC; Wong YL
J Cutan Pathol; 2003 Sep; 30(8):479-85. PubMed ID: 12950498
[TBL] [Abstract][Full Text] [Related]
20. Mutation analysis of DMBT1 in glioblastoma, medulloblastoma and oligodendroglial tumors.
Pang JC; Dong Z; Zhang R; Liu Y; Zhou LF; Chan BW; Poon WS; Ng HK
Int J Cancer; 2003 May; 105(1):76-81. PubMed ID: 12672033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
